Business
Voyageur Pharmaceuticals Announces Shareholder Update and Filing of Frances Creek Preliminary Economic Assessment Report
(TheNewswire) Calgary, Alberta - TheNewswire – February 24, ...
About this update from Voyageur Pharmaceuticals Ltd
[{"type":"text","content":"Voyageur Pharmaceuticals Announces Shareholder Update and Filing of Frances Creek Preliminary Economic Assessment Report\n \n \n (TheNewswire)\n \n \n \n \n \n \n \n \n \n Calgary, Alberta -\n \n \n TheNewswire\n \n \n – February 24, 2022\n \n \n :\n \n \n Voyageur Pharmaceuticals Ltd.\n(“\n \n \n Voyageur\n \n \n ” or the “\n \n \n Company\n \n \n ”) (TSXV:VM)\n \n \n (OTC:VYYRF)\n \n \n is pleased to announce the\nfiling of its Preliminary Economic Assessment (“\n \n \n PEA\n \n \n ”) for the\ndevelopment of its Frances Creek pharmaceutical barium sulfate project\n(the “\n \n \n Project\n \n \n ”), located in British Columbia, Canada. The PEA was\ninitially disclosed in a news release dated January 11, 2022 and was\nprepared by SGS Geological Services (“\n \n \n SGS\n \n \n ”). The\neffective date of the PEA is January 11, 2022 and the technical report\nrelating to the PEA has been filed on SEDAR.\n \n \n \n \n Project Update\n \n \n \n \n Brent Willis, CEO of Voyageur, states in a letter to\nshareholders:\n \n \n \n \n Dear Shareholders,\n \n \n \n \n We would like to express our gratitude for your\ncontinuous support of our company. I look back at what we have\naccomplished since going public in 2017. We have come a long way and\nhave completed many milestones. The following is a review of the most\nimportant milestones that have shaped us into the developing\npharmaceutical company we are today:\n \n \n \n \n \n \n Discovery of the Frances Creek high purity barium\nproject in BC, Canada.\n \n \n \n \n \n \n Completed successful drilling program that highlighted\na resource of high purity barium sulfate.\n \n \n \n \n \n \n Restructured the company’s management team with the\nvision of fully integrating the radiology health care drug device\nmarkets.\n \n \n \n \n \n \n Created a new board of directors with a focus on\nindependence, strong business backgrounds\n \n \n business acumen, corporate governance, and strong\nethics.\n \n \n \n \n \n \n Advancing the transition of the company from a mineral\nexplorer into a fully integrated pharmaceutical manufacturing\ncompany.\n \n \n \n \n \n \n Developed relationships with local manufacturing\nexpertise to launch product lines to market in advance of the Frances\nCreek quarry start up.\n \n \n \n...